Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
A.forall Launches Generic Tromethamine With 180-Day US Exclusivity
Launch Marks The Second A.forall Product With The Coveted CGT Designation
Feb 05 2025
•
By
Adam Zamecnik
Teva has settled with “all 50 states and 99% of litigating subdivisions” • Source: Shutterstock
More from Business
More from Generics Bulletin